Robert W. Baird Increases Intuitive Surgical (NASDAQ:ISRG) Price Target to $565.00

Intuitive Surgical (NASDAQ:ISRG) had its price target raised by Robert W. Baird from $503.00 to $565.00 in a report released on Thursday, MarketBeat Ratings reports. Robert W. Baird currently has an outperform rating on the medical equipment provider’s stock.

Other equities research analysts have also issued research reports about the stock. Royal Bank of Canada upped their target price on shares of Intuitive Surgical from $515.00 to $525.00 and gave the stock an “outperform” rating in a report on Tuesday, October 8th. Barclays raised their price objective on shares of Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a report on Thursday, July 18th. BTIG Research boosted their target price on Intuitive Surgical from $494.00 to $518.00 and gave the stock a “buy” rating in a report on Monday, October 14th. Redburn Atlantic raised Intuitive Surgical from a “neutral” rating to a “buy” rating and raised their price target for the company from $380.00 to $510.00 in a report on Friday, August 2nd. Finally, Raymond James lifted their price objective on Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research report on Monday, October 14th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $513.74.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $521.15 on Thursday. Intuitive Surgical has a one year low of $254.85 and a one year high of $523.34. The stock has a fifty day moving average price of $483.85 and a 200 day moving average price of $438.56. The stock has a market cap of $184.85 billion, a P/E ratio of 94.07, a price-to-earnings-growth ratio of 5.40 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, beating the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The company had revenue of $2.01 billion for the quarter, compared to analyst estimates of $1.97 billion. During the same period in the prior year, the company posted $1.18 EPS. The company’s revenue was up 14.5% compared to the same quarter last year. Equities research analysts anticipate that Intuitive Surgical will post 5.22 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Craig H. Barratt sold 1,400 shares of the firm’s stock in a transaction on Tuesday, July 23rd. The stock was sold at an average price of $458.13, for a total value of $641,382.00. The transaction was disclosed in a document filed with the SEC, which is available through this link. In related news, Director Craig H. Barratt sold 1,400 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total transaction of $641,382.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Myriam Curet sold 2,818 shares of the company’s stock in a transaction that occurred on Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total transaction of $1,291,010.34. Following the completion of the sale, the executive vice president now directly owns 298 shares of the company’s stock, valued at $136,522.74. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 53,120 shares of company stock worth $25,528,753. Insiders own 0.90% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Creekmur Asset Management LLC raised its position in shares of Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 42 shares during the period. Ridgewood Investments LLC acquired a new position in shares of Intuitive Surgical in the 2nd quarter valued at approximately $26,000. Delos Wealth Advisors LLC increased its stake in Intuitive Surgical by 380.0% during the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 57 shares in the last quarter. Godsey & Gibb Inc. raised its holdings in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares during the period. Finally, LRI Investments LLC bought a new position in Intuitive Surgical in the first quarter valued at approximately $30,000. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.